期刊文献+

格列齐特片的制备工艺和溶出一致性评价 被引量:4

Preparation of gliclazide tablets and consistency study of their dissolubility
原文传递
导出
摘要 目的制备格列齐特片,进行体外溶出一致性评价。方法通过单因素实验考察黏合剂的浓度、外加崩解剂的量、外加润滑剂和助流剂的量、颗粒的大小和片剂的硬度几个因素对溶出的影响,进行处方工艺的筛选。放大制备3批格列齐特片,考察在4种不同溶出介质中自制片和参比制剂的溶出一致性。结果 3批自制片在磷酸盐缓冲液(pH7.4)中15 min内溶出大于85%,在水、pH1.2盐酸溶液、pH6.0磷酸盐溶液中的f_2均大于50。结论在4种不同的溶出介质中,自制片与参比制剂体外溶出一致。 Objective To prepare gliclazide tablets and to evaluate its consistency of dissolution tests. Methods The single factor experiments were applied to investigating several factors on the dissolution, such as the amount of the adhesive, the amount of lubricant, the particle size and tablet hardness.708-DS Dissolution Tester was used to conduct the dissolution tests which were carried on four different dissolution media. Then the similar factor(f2) was adopted to evaluate the similarity of dissolution between the original drug and generic drug. Results Three batches of homemade-tablets were eluted more than 85% within 15 min in phosphate buffered saline(pH7.4), and the f2 values were greater than 50 in water, pH 1.2 hydrochloric acid solution and pH 6.0 phosphate solution. Conclusion In four different dissolution media, self-made tablets and reference formulations in vitro dissolution consistent.
作者 雷炜 彭龙 陶敏 李志平 梅兴国 肖若蕾 LEI Wei;PENG Long;TAO Min;LI Zhiping;MEI Xingguo;XIAO Ruolei(Pharmaceutical College of Hubei University of Science and Technology, Xiarming 437000, China;Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China;Henan Fu Jen Catholic Medical Technology Development Co., Ltd., Henan, Zhengzhou 450000, China)
出处 《药物评价研究》 CAS 2018年第5期821-827,共7页 Drug Evaluation Research
基金 国家"重大新药创制"科技重大专项资助项目(2012ZX09301003-001-009)
关键词 格列齐特片 处方工艺 溶出曲线 一致性评价 gliclazide tablets prescription technique dissolution curve consistency assessment
  • 相关文献

参考文献1

二级参考文献14

  • 1谢沐风,操洪欣.溶出度测定中的若干问题[J].中国医药工业杂志,2006,37(12):859-862. 被引量:49
  • 2《药品注册管理办法》(局令第28号)[EB/OL].(2007-07-10)http:www.sda.gov.cn/WS01/CL0053/24529.html.
  • 3CDE网站开通“日本药品体外溶出试验信息库”的通知[EB/OL].[2011-01-28].http://www.cde.org.cn/news.do?method=viewlnfoCommon&id=312014.
  • 4Guidance on the selection of comparator pharmaceutical products for equivalence assessment of interchangeable multisource(generic) products[EB/OL].http://www.who.int/medicines/areas/quality_safety/quality_assurance/regulatory standards/en/index.html.
  • 5世界卫生组织.药品质量控制与质量保证管理规范世界卫生组织药品标准专家委员会第36次技术报告(世界卫生组织技术报告丛书)[M].丁丽霞,主译.北京:人民卫生出版社,2003:136.
  • 6关于印发化学药品技术标准等5个药品审评技术标准的通知[EB/OL].[2008-06-03].http://www.sfda.gov.cn/WS01/CL0844/30470.html.
  • 7审评三部.抗生素类药物杂质控制研究的技术要求[EB/OL].[2010-04-06].http://www.cde.org.cn/dzkw.do?method=largePage&id=311648.
  • 8黄晓龙.关于药学对比研究的几点要求[EB/OL].[2010-07-27].http://www.cde.org.cn/dzkw.do?method=largePage&id=311788.
  • 9化药药学二部.关于生物等效性试验参比制剂的选择[EB/OL].[2012-01-14].http://www.cde.org.cn/dzkw.do?method=largePage&id=312583.
  • 10谢沐风.制药行业的高科技在制剂上[EB/OL].[2014-02-27].http://www.y-lp.com/chrome/index.htm?r=/chrome/cases/show_Essay/De faultDetail.htm?essayKey=6352912399120387437.

共引文献4

同被引文献28

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部